Should I start lisinopril (an ACE inhibitor) in a normotensive patient with acute decompensated heart failure who is already on metoprolol and diltiazem, has good renal function, occasional systolic blood pressure in the 157 mm Hg range, bilateral pitting edema, no crackles, and no jugular venous distension?

Yes, Add Lisinopril with Diuretics, But Address the Diltiazem First

You should initiate lisinopril in this patient with acute decompensated heart failure (ADHF), but first discontinue or significantly reduce the diltiazem, as calcium channel blockers like diltiazem are potentially harmful in systolic heart failure and should be avoided unless absolutely necessary. 1, 2

Critical First Step: Discontinue Diltiazem

Diltiazem has negative inotropic effects and is not recommended in patients with heart failure with reduced ejection fraction (HFrEF) because it increases the risk of worsening heart failure and hospitalizations 2. The 2012 ESC guidelines explicitly state that calcium channel blockers should be discontinued in patients with systolic HF unless absolutely necessary, and diltiazem and verapamil are potentially harmful 1. Recent data confirms diltiazem increases worsening heart failure risk, particularly in critically ill patients requiring hospital admission 3.

• Action: Stop diltiazem immediately unless there's an absolute indication (e.g., uncontrolled atrial fibrillation despite other agents)
• The metoprolol alone should provide adequate rate control if needed

Why ACE Inhibitor is Essential in ADHF

ACE inhibitors are Class I, Level A recommendations for all patients with heart failure and fluid retention 4. The guidelines are unequivocal:

• In patients with fluid retention (which your patient has—bilateral pitting edema), ACE inhibitors must be given together with diuretics 4
• ACE inhibitors improve survival, symptoms, functional capacity, and reduce hospitalizations in heart failure with left ventricular systolic dysfunction 4
• They should be initiated even in patients with signs or symptoms of heart failure, even if transient 4

Addressing the Blood Pressure Concern

The systolic BP of 157 mmHg actually supports rather than contradicts ACE inhibitor initiation:

• Guidelines note that "changes in systolic and diastolic blood pressure and increases in serum creatinine are usually small in normotensive patients" 4
• The GISSI-3 trial specifically included patients with systolic BP >100 mmHg and showed mortality benefit 5
• Asymptomatic low blood pressure does not require treatment changes 1
• His occasional elevation to 157 mmHg suggests he has adequate BP reserve for ACE inhibitor initiation

Practical Initiation Protocol

Start low and titrate up 4:

1. Initial dose: Lisinopril 2.5 mg daily (standard starting dose) 4
2. Target dose: 5-20 mg daily, with evidence supporting higher doses (32.5-35 mg) for better outcomes 4, 6
3. Titration: Double dose every 1-2 weeks if tolerated 4

Essential Monitoring

Monitor the following parameters 4:

• Renal function and potassium: Check before starting, 1-2 weeks after each dose increment, then at 3-6 month intervals
• Blood pressure: Monitor for symptomatic hypotension (though asymptomatic low BP is acceptable)
• Signs of congestion: Weight, edema, dyspnea

Concomitant Diuretic Management

Since he has bilateral pitting edema (volume overload):

• Continue or optimize loop diuretics for symptomatic relief 4
• Diuretics are Class I, Level A for fluid overload 4
• The combination of ACE inhibitor + diuretic is the standard approach 4

Common Pitfalls to Avoid

1. Don't wait for "perfect" blood pressure: The occasional 157 mmHg reading is not a contraindication; hypotension <100 mmHg systolic would be 5
2. Don't continue diltiazem: This is actively harmful in systolic HF 1, 2
3. Don't undertitrate: The ATLAS trial showed high-dose lisinopril (32.5-35 mg) reduced hospitalizations by 24% compared to low-dose (2.5-5 mg) 4, 6, 7
4. Don't stop for small creatinine increases: Up to 30% increase in creatinine or up to 3 mg/dL is generally acceptable unless accompanied by hyperkalemia >5.5 mEq/L 5

Contraindications to Watch For

ACE inhibitors are contraindicated in 4, 5:

• Bilateral renal artery stenosis
• History of angioedema with prior ACE inhibitor
• Current angioedema
• Pregnancy

Your patient has good renal function, making this safer.

The Bottom Line

Discontinue diltiazem, initiate lisinopril 2.5 mg daily with continued diuretic therapy, and monitor renal function and potassium in 1-2 weeks. The combination of ACE inhibitor plus beta-blocker (metoprolol) plus diuretics represents guideline-directed medical therapy for ADHF and will improve both symptoms and long-term outcomes 8, 2, 9.